Home / Education / Education Courses / Substance Use Disorders: A Comprehensive Review and Update 2023

Substance Use Disorders: A Comprehensive Review and Update 2023

Event Date(s): Feb 19, 2023 - 09:00am to Feb 22, 2023 - 04:50pm

Attend this live conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.

Available Credits: 17.00 AMA PRA Category 1 Credit™ 17.00 Nursing Contact Hours 17.00 Social Workers 17.00 Participation 17.00 Psychologists CE Credit Register For This Course

Course Details

We invite you to join us at Disney's Grand Floridian Resort & Spa for our annual Substance Use Disorder conference. 

Please click on the "Venue" tab to see our available room block offerings.

Attend this conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.

Substance use disorders are complex and have a huge impact on patients, families and communities They challenge even experienced health care professionals to stay current with evolving guidelines.  And they are seen and treated across all professions, disciplines and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.

That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.


Pricing

MDs/Doctoral-Level Professionals
Regular Registration (after January 13, 2023): $995.00

Other Professionals or Trainees
Regular Registration (after January 13, 2023): $895.00

Sunday, February 19, 2023
Buprenorphine Waiver Training: $50
This is a ticketed event, NO CME CREDIT


*New* Virtual Registration

We are now adding a full virtual option to accommodate those who can not attend in person. Full more information and to register, please click the link below. 

Substance Use Disorders 2023: Virtual Registration - Click Here


E-SYLLABUS


We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 


Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by January 18, 2023. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

 

 

 

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

PCSS website link: www.pcssNOW.org
Contact information: pcss@aaap.org
AAAP is the DATA 2000 sponsor for this training.


Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition

Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.

Purchase a print copy of our Board Preparation book here!


 

Course Summary

Available Credits:17.00 AMA PRA Category 1 Credit™ 17.00 Nursing Contact Hours 17.00 Social Workers 17.00 Participation 17.00 Psychologists CE Credit
Course Topic:Substance Use
Course Format:Conference
Target Audience:

This program is intended for:

  • General and Family Physicians
  • Psychiatrists
  • Nurse Practitioners 
  • Physician Assistants
  • Nurses
  • Psychologists
  • Social Workers
Event Starts: Feb 19, 2023 - 09:00am
Event Ends: Feb 22, 2023 - 04:50pm
Cost: $995.00

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

  • Describe the best practices for treatment of substance use disorders
  • Discuss how to properly screen and diagnose substance use disorders
  • List rational, evidence based pharmacologic and non-pharmacologic therapies for patients with substance use disorders
  • Assess relative utility and strengths of recovery oriented models of care
  • Assess and treat patients with co-morbid substance use, mood disorders, anxiety disorders, ADHD, pain, and infectious diseases.
  • Discuss how to manage complicated withdrawal
  • Utilize motivational interviewing, CBT and contingency management techniques when working with patients suffering from substance use disorders
  • Describe the effects of and interventions for marijuana and synthetics
  • List the different approaches and challenges associated with opioid, alcohol and nicotine treatment
  • Discuss the challenges associated with identification and management of substance use disorders in the emergency department

Important: Buprenorphine (MAT) Waiver Training Registrants 

You will need to create an account in the PCSS system ahead of the live training.  If you do not set up an account and enroll in your training ahead of time, it will delay your ability to complete the online half and receive their certificate of completion. Please use this link to create an account https://education.sudtraining.org/Public/Registration.aspx Once you have created an account in the PCSS system, please use this link to enroll in the online half of this course: https://education.sudtraining.org/Users/InvitationCode.aspx You will submit this code: WAIVER-250359-11951

Once you have entered the invitation code, click “Get Started”, you will have access to the online half of the training. You may complete the online half before or after our live training. After the live training our staff will indicate your attendance. Once both halves of the training are complete you may return to the PCSS platform, complete their evaluation and claim your waiver training certificate.

Effective December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act):

  • All DEA registrants should be aware of the following:
  • A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.
  • Going forward, all prescriptions for buprenorphine only require a standard DEA registration number. The previously used DATA-Waiver registration numbers are no longer needed for any prescription.
  • There are no longer any limits or patient caps on the number of patients a prescriber may treat for opioid use disorder with buprenorphine.
  • The Act does not impact existing state laws or regulations that may be applicable.

While no longer required, the Act also introduced new training requirements for all prescribers who are not board certified in addiction medicine. These requirements will go into effect June 21, 2023, and the DEA and SAMHSA are actively working to provider further guidance.

As such, the MGH Psychiatry Academy welcomes all providers who plan to treat patients with opioid use disorder to make use of existent waiver trainings and other educational resources. Please continue to check https://www.samhsa.gov/medication-assisted-treatment/removal-data-waiver-requirement for further updates and guidance.